| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036500 Use of sustained release oral solid dosage form; side effect reduction of liver damage |
| 02/05/2009 | US20090036494 Administration of Pharmaceuticals |
| 02/05/2009 | US20090036491 Transdermal pharmaceutical delivery compositions |
| 02/05/2009 | US20090036417 Cochleates without metal cations as bridging agents |
| 02/05/2009 | US20090036414 Mesalamine Formulations |
| 02/05/2009 | US20090036393 Vesicular monoamine transporter gene therapy in Parkinson's disease |
| 02/05/2009 | US20090036392 Composition comprising biodegradable hydrating ceramics for controlled drug delivery |
| 02/05/2009 | US20090036389 Polymeric Micelle Formulations of Hydrophobic Compounds and Methods |
| 02/05/2009 | US20090036360 Medicament containing activated antithrombin iii |
| 02/05/2009 | US20090036352 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 02/05/2009 | US20090035714 Methods and systems for concurrent tooth repositioning and substance delivery |
| 02/05/2009 | US20090035381 Electrospraying method for fabrication of particles and coatings and treatment methods thereof |
| 02/05/2009 | US20090035379 Fenofibrate compositions |
| 02/05/2009 | US20090035378 Nanostructured bioactive materials prepared by dual nozzle spray drying techniques |
| 02/05/2009 | US20090035377 Composition and method for controlling drug delivery from silicone adhesive blends |
| 02/05/2009 | US20090035376 Stem cells obtained from pulp of deciduous or permanent teeth and of dental germ, able to produce human bone tissue |
| 02/05/2009 | US20090035375 Pharmaceutical compositions for acute glucocorticoid therapy |
| 02/05/2009 | US20090035374 Method of making a single-stage pharmaceutical preparation for oral therapy to regulate blood pressure and kit containing same |
| 02/05/2009 | US20090035373 Pharmaceutical composition for contraception and blood pressure regulation, kit for contraception containing same and method of production of same |
| 02/05/2009 | US20090035372 method for manufacturing a pharmaceutical composition for controlled release of an active substance |
| 02/05/2009 | US20090035371 Tablet with remedial composition and methods for treating medical disorders and ailments |
| 02/05/2009 | US20090035370 Dosage form and method of use |
| 02/05/2009 | US20090035369 Composition and Methods for Treating and Preventing Age-Related Macular Degeneration |
| 02/05/2009 | US20090035368 Embedded micellar nanoparticles |
| 02/05/2009 | US20090035367 Controlled degradation of expandable polymers in gastric volume reduction treatment |
| 02/05/2009 | US20090035366 Nanoparticulate benzothiophene formulations |
| 02/05/2009 | US20090035365 Density Controlled Capsule Particles and Methods of Making the Same |
| 02/05/2009 | US20090035364 Para-substituted 2-alkoxyphenol compounds |
| 02/05/2009 | US20090035363 Photoactive Compounds and Compositions and Uses Thereof |
| 02/05/2009 | US20090035362 Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss |
| 02/05/2009 | US20090035361 Composition for vaginal use |
| 02/05/2009 | US20090035360 Lyophilised antigen composition |
| 02/05/2009 | US20090035359 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 02/05/2009 | US20090035358 Phosphatidyl oligoglycerols |
| 02/05/2009 | US20090035357 Method of drug delivery using a transdermal device having a phase change material |
| 02/05/2009 | US20090035356 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 02/05/2009 | US20090035355 Confectionery products and process for obtaining them |
| 02/05/2009 | US20090035354 Device and Method for Treating the Anal Sphincter |
| 02/05/2009 | US20090035353 Non-absorbent articles containing additives |
| 02/05/2009 | US20090035352 Drug Delivery Particle |
| 02/05/2009 | US20090035350 Polymers for implantable devices exhibiting shape-memory effects |
| 02/05/2009 | US20090035348 Dissolution of arterial plaque |
| 02/05/2009 | US20090035342 Antimicrobial Devices and Compositions |
| 02/05/2009 | US20090035340 Preservative compositions for moist wipes |
| 02/05/2009 | US20090035339 Methods of Inactivating Viruses |
| 02/05/2009 | US20090035338 Inverse emulsions comprising avermectins and cosmetic/dermatological applications thereof |
| 02/05/2009 | US20090035336 Isoflavone nanoparticles and use thereof |
| 02/05/2009 | US20090035332 Pharmaceutical formulation |
| 02/05/2009 | US20090035331 Systems and Methods for Targeted and Controlled Delivery of Agents |
| 02/05/2009 | US20090035264 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities |
| 02/05/2009 | US20090035257 Devices, compositions and methods for the protection and repair of cells and tissues |
| 02/05/2009 | US20090035253 Poly(lactide-Co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar |
| 02/05/2009 | US20090035252 Method of inducing a CTL response |
| 02/05/2009 | US20090035226 Use of cranberry extract enriched in total phenols and free, essentially free, or substantially free of sugars, acids, sulfur and other contaminants, for periodontal treatment |
| 02/05/2009 | US20090035225 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 02/05/2009 | US20090035223 Biomimetic iron-oxide-containing lipoprotein and related materials |
| 02/05/2009 | DE102007036319A1 Vorrichtung zum Erwärmen von Umgebungsluft zum Zwecke der Inhalation A means for heating ambient air for the purpose of inhalation |
| 02/05/2009 | DE102007036101A1 Neue glycolidreiche Copolymere New glycolidreiche copolymers |
| 02/05/2009 | CA2705625A1 Improved formulations of candesartan |
| 02/05/2009 | CA2698305A1 Effervescent solid pharmaceutical composition comprising dextrose and process for its preparation |
| 02/05/2009 | CA2695214A1 Transdermal administration of (2s)-(4e)-n-methyl-5-(3-(5-is0pr0p0xypyridin)yl)-4-penten-2-amine |
| 02/05/2009 | CA2695178A1 Methods for producing aripiprazole suspension and freeze-dried formulation |
| 02/05/2009 | CA2695157A1 Compositions, uses, and method of making wound care products from naturally occurring food ingredients |
| 02/05/2009 | CA2694602A1 Pulsatile gastric retentive dosage forms |
| 02/05/2009 | CA2694516A1 Direct compressible dextrose |
| 02/05/2009 | CA2694378A1 Pharmaceutical compositions and process for making them |
| 02/05/2009 | CA2692975A1 Stable liquid pharmaceutical composition based on trazodone |
| 02/05/2009 | CA2681021A1 Single-phase pharmaceutical composite preparation (dienogest and ethinyl estradiol) for oral therapy for regulation of blood pressure |
| 02/04/2009 | EP2020438A1 Treatment of pompe's disease |
| 02/04/2009 | EP2020256A1 Sulfur containing dermatological compositions |
| 02/04/2009 | EP2020245A1 Device for ophthalmic treatments and methods for making said device |
| 02/04/2009 | EP2020243A1 Topically applicable pharmaceutical preparation |
| 02/04/2009 | EP2020242A2 Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease |
| 02/04/2009 | EP2020236A1 Contraceptive medicament based on a progestative and oestrogen, method for producing the same, and use |
| 02/04/2009 | EP2020235A1 Method for manufacturing a single-phase pharmaceutical preparation for oral treatment to regulate blood pressure |
| 02/04/2009 | EP2020229A1 Multiparticulate modified release composition |
| 02/04/2009 | EP2020221A1 DMS (Derma Membrane Structure) in foaming creams |
| 02/04/2009 | EP2019952A2 Stabilized formulation of triamcinolone acetonide |
| 02/04/2009 | EP2019670A2 Microspheroidal-controlled release of biomolecules |
| 02/04/2009 | EP2019669A1 Oral preparation comprising pioglitazone |
| 02/04/2009 | EP2019668A1 Pharmaceutical composition comprising candesartan cilexetil |
| 02/04/2009 | EP2019667A2 Detection and imaging of target tissue |
| 02/04/2009 | EP2019666A2 Pharmaceutical preparations for transdermal use |
| 02/04/2009 | EP2019665A1 Drug release from nanoparticle-coated capsules |
| 02/04/2009 | EP2019664A1 Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same |
| 02/04/2009 | EP2019663A2 Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof |
| 02/04/2009 | EP2019645A2 Delivery of ophthalmologic agents to the exterior or interior of the eye |
| 02/04/2009 | EP1827397B1 Over dosage indicating medicated film strip |
| 02/04/2009 | EP1596895B1 Occlusion resistant hydrocephalic shunt |
| 02/04/2009 | EP1596842B1 Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
| 02/04/2009 | EP1534237B1 Orally disintegrating tablets and process for obtaining them. |
| 02/04/2009 | EP1515699B1 Process for loading and thermodynamically activating drugs on polymers by means of supercritical fluids |
| 02/04/2009 | EP1414410B1 Nanoparticulate formulations of fenofibrate |
| 02/04/2009 | EP0881906B2 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 02/04/2009 | CN201189303Y External traditional Chinese medicine plaster for treating mouth and tongue sore |
| 02/04/2009 | CN201189302Y Plaster |
| 02/04/2009 | CN201189301Y Medical hot plaster |
| 02/04/2009 | CN201189290Y Stype manufacturing packaging machine |
| 02/04/2009 | CN101360507A Method of using guava extract and composition including guava extract |